Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 4 Compare versions History 17 Sponsors

Jun 2, 2026 · Senate

SUBSTITUTED FOR S9279A

Jun 2, 2026 · Senate

3RD READING CAL.1239

Jun 2, 2026 · Senate

PASSED SENATE

Jun 2, 2026 · Senate

RETURNED TO ASSEMBLY

Mar 23, 2026 · Assembly

PASSED ASSEMBLY

Mar 23, 2026 · Assembly

DELIVERED TO SENATE

Mar 23, 2026 · Senate

REFERRED TO HEALTH

Mar 19, 2026 · Assembly

ADVANCED TO THIRD READING CAL.315

Mar 17, 2026 · Assembly

REPORTED

Mar 12, 2026 · Assembly

AMEND AND RECOMMIT TO HEALTH

Mar 12, 2026 · Assembly

PRINT NUMBER 3283C

Feb 23, 2026 · Assembly

AMEND AND RECOMMIT TO HEALTH

Feb 23, 2026 · Assembly

PRINT NUMBER 3283B

Jan 7, 2026 · Assembly

REFERRED TO HEALTH

Mar 12, 2025 · Assembly

AMEND (T) AND RECOMMIT TO HEALTH

Mar 12, 2025 · Assembly

PRINT NUMBER 3283A

Jan 27, 2025 · Assembly

REFERRED TO HEALTH

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from NY's completed sessions
Momentum +2 58/100 from the pace of recorded action
Time since last action -18 132 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.